LAMTOR3 and breast carcinoma: Due to the well established role of both signalling cascades in breast cancer progression, and the recent implication of LAMTOR3 in oestrogen receptor positive breast cancer, we leave open the possibility of therapeutically targeting the complex as previously proposed by others [26].